SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950133-09-001104
Filing Date
2009-04-14
Accepted
2009-04-14 10:31:47
Documents
5
Period of Report
2009-05-28
Effectiveness Date
2009-04-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A w73508def14a.htm DEF 14A 430211
2 GRAPHIC w73508w7350800.gif GRAPHIC 3606
3 GRAPHIC w73508w7350801.gif GRAPHIC 2732
4 GRAPHIC w73508w7350804.gif GRAPHIC 1514
5 GRAPHIC w73508w7350803.gif GRAPHIC 1936
  Complete submission text file 0000950133-09-001104.txt   445724
Mailing Address 4520 EAST-WEST HIGHWAY, SUITE 300 BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, SUITE 300 BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33609 | Film No.: 09747871
SIC: 2834 Pharmaceutical Preparations